A detailed history of Financial Engines Advisors L.L.C. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Engines Advisors L.L.C. holds 27,437 shares of ABT stock, worth $3.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,437
Previous 28,388 3.35%
Holding current value
$3.18 Million
Previous $2.95 Million 6.07%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $95,166 - $112,341
-951 Reduced 3.35%
27,437 $3.13 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $56,710 - $63,303
563 Added 2.02%
28,388 $2.95 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $362,730 - $400,619
-3,312 Reduced 10.64%
27,825 $3.16 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $294,470 - $360,456
3,265 Added 11.71%
31,137 $3.43 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $211,694 - $253,997
-2,216 Reduced 7.37%
27,872 $2.7 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $341,140 - $380,101
-3,385 Reduced 10.11%
30,088 $3.28 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $196,238 - $230,984
2,026 Added 6.44%
33,473 $3.39 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $353,052 - $414,185
-3,714 Reduced 10.56%
31,447 $3.45 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $658,161 - $762,028
-6,802 Reduced 16.21%
35,161 $3.4 Million
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $38,378 - $46,387
-376 Reduced 0.89%
41,963 $4.56 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $187,106 - $228,164
1,641 Added 4.03%
42,339 $5.01 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $683,475 - $836,877
-5,916 Reduced 12.69%
40,698 $5.73 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $5.44 Million - $6.02 Million
46,614 New
46,614 $5.51 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $6.44 Million - $7.58 Million
-60,863 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$108.84 - $128.23 $444,176 - $523,306
-4,081 Reduced 6.28%
60,863 $7.29 Million
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $1.39 Million - $1.52 Million
13,265 Added 25.67%
64,944 $7.11 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $698,755 - $848,586
-7,625 Reduced 12.86%
51,679 $5.62 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $299,235 - $382,984
-3,908 Reduced 6.18%
59,304 $5.42 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $87,633 - $128,144
-1,395 Reduced 2.16%
63,212 $4.99 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $121,062 - $134,770
-1,542 Reduced 2.33%
64,607 $5.61 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $335,380 - $363,656
4,098 Added 6.6%
66,149 $5.54 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $406,961 - $474,640
-5,584 Reduced 8.26%
62,051 $5.22 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $442,680 - $535,201
-6,685 Reduced 8.99%
67,635 $5.41 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $204,284 - $231,425
3,116 Added 4.38%
74,320 $5.38 Million
Q3 2018

Nov 02, 2018

SELL
$60.81 - $73.36 $1.22 Million - $1.47 Million
-20,082 Reduced 22.0%
71,204 $5.2 Million
Q2 2018

Jul 27, 2018

SELL
$57.57 - $63.54 $463,380 - $511,433
-8,049 Reduced 8.1%
91,286 $5.57 Million
Q1 2018

May 02, 2018

SELL
$56.27 - $63.62 $1.4 Million - $1.58 Million
-24,823 Reduced 19.99%
99,335 $5.95 Million
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $2.31 Million - $2.48 Million
-43,114 Reduced 25.77%
124,158 $7.09 Million
Q3 2017

Nov 07, 2017

BUY
$48.06 - $53.64 $8.04 Million - $8.97 Million
167,272
167,272 $8.93 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Engines Advisors L.L.C. Portfolio

Follow Financial Engines Advisors L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Engines Advisors L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Financial Engines Advisors L.L.C. with notifications on news.